Biosimilar Newsletter Archive

  1. 04.18.19 -- 3 Crucial Biosimilar Discussions To Note
    4/18/2019
    04/18/19 Biosimilar Development Newsletter
  2. 04.17.19 -- Trends In Bioprocess Development - Top Discussions From Bioprocessing Asia
    4/17/2019
    04/17/19 Biosimilar Development Newsletter
  3. 04.12.19 -- Are You Ready For The Changing Biopharma Pipeline?
    4/12/2019
    04/12/19 Biosimilar Development Newsletter
  4. 04.11.19 -- Rebates & Biosimilars: Employers Tell All
    4/11/2019
    04/11/19 Biosimilar Development Newsletter
  5. 04.04.19 -- Top 4 Takeaways From The BioTech Pharma Summit
    4/4/2019
    04/04/19 Biosimilar Development Newsletter
  6. 03.28.19 -- Are Biologics Facing A Buy-And-Bill Renaissance?
    3/28/2019
    03/28/19 Biosimilar Development Newsletter
  7. 03.21.19 -- Why These Two Biosimilar Policies Raise Questions
    3/21/2019
    03/21/19 Biosimilar Development Newsletter
  8. 03.14.19 -- Biosimilar Success: It's Not That Risky To Attain
    3/14/2019
    03/14/19 Biosimilar Development Newsletter
  9. 03.07.19 -- How Can FDA Fix The Biosimilar Pathway?
    3/7/2019
    03/07/19 Biosimilar Development Newsletter
  10. 03.05.19 -- Integrating Automation And Data Science To Optimize Process Strategies
    3/5/2019
    03/05/19 Biosimilar Development Newsletter